Evidence map›Paper›PMID 34296998›Full record

ArticleeLife2021

Impact of asymptomatic

Kelsey M Sumner, Judith N Mangeni, Andrew A Obala, Elizabeth Freedman, Lucy Abel, Steven R Meshnick, Jessie K Edwards, Brian W Pence, Wendy Prudhomme-O'Meara, Steve M Taylor

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Genotypic analysis of RTS,S/AS01The Lancet. Infectious diseases · 2024
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Kelsey M SumnerDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, United States.
Judith N MangeniSchool of Public Health, College of Health Sciences, Moi University, Eldoret, Kenya.
Andrew A ObalaSchool of Medicine, College of Health Sciences, Moi University, Eldoret, Kenya.
Elizabeth FreedmanDivision of Infectious Diseases, School of Medicine, Duke University, Durham, United States.
Lucy AbelAcademic Model Providing Access to Healthcare, Moi Teaching and Referral Hospital, Eldoret, Kenya.
Steven R MeshnickDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, United States.
Jessie K EdwardsDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, United States.
Brian W PenceDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, United States.
Wendy Prudhomme-O'Meara *Division of Infectious Diseases, School of Medicine, Duke University, Durham, United States.
Steve M Taylor *Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, United States.ORCID 0000-0002-2783-0990
University of North Carolina at Chapel Hill · USMoi University · KEAMPATH · KEDuke University · US

Funding

Once bitten: A longitudinal, observational study of successful malaria parasite transmission events between humans and mosquitosR01AI146849 · NIAID · DUKE UNIVERSITY · PI PRUDHOMMEOMEARA, WENDY, TAYLOR, STEVE MYER · 2019 to 2023
$3.0M
Spatial Scales of Plasmodium Falciparum Generations; Implications for EliminationR21AI126024 · NIAID · DUKE UNIVERSITY · PI PRUDHOMMEOMEARA, WENDY · 2017 to 2018
$338k
NIAID NIH HHS R01 AI146849NIAID NIH HHS R21 AI126024
6 · The paper itself

Abstract

Background: Asymptomatic Methods: In a 29-month cohort of 268 people in Western Kenya, we investigated the association between asymptomatic Results: Compared to being uninfected, asymptomatic infections were associated with an increased 1 month likelihood of symptomatic malaria (adjusted hazard ratio [aHR]: 2.61, 95% CI: 2.05 to 3.33), and this association was modified by sex, with females (aHR: 3.71, 95% CI: 2.62 to 5.24) at higher risk for symptomaticity than males (aHR: 1.76, 95% CI: 1.24 to 2.50). This increased symptomatic malaria risk was observed for asymptomatic infections of all densities and in people of all ages. Long-term risk was attenuated but still present in children under age 5 (29-month aHR: 1.38, 95% CI: 1.05 to 1.81). Conclusions: In this high-transmission setting, asymptomatic Funding: This work was supported by the National Institute of Allergy and Infectious Diseases (R21AI126024 to WPO, R01AI146849 to WPO and SMT).

Indexed as

AdolescentAdultAgedAged, 80 and overAge FactorsAsymptomatic InfectionsChildChild, PreschoolFemaleHumansInfantKenyaLongitudinal StudiesMalaria, FalciparumMaleMiddle Agedasymptomatic infectionepidemiologyglobal healthinfectious diseasemalariamicrobiologyparasite density

Identifiers

PMID34296998
PMCPMC8337072
OpenAlexW3183954521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.